ALFRED I DUPONT HOSP FOR CHILDREN
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $14.8M
- Transactions
- 5,914
- Companies
- 40
- Average per transaction
- $2,500
Who reported the payments
| Vertex | $1,800,933 |
| Pfizer | $1,424,511 |
| Novo Nordisk | $1,270,893 |
| AbbVie | $1,125,573 |
| Biomarin Pharmaceutical Inc. | $946,722 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | $757,920 |
| Jazz Pharmaceuticals Inc. | $698,955 |
| Novo Nordisk AS | $698,819 |
| Eli Lilly | $534,625 |
| Biogen | $530,941 |
| Harmony Biosciences LLC | $458,750 |
| Travere Therapeutics, Inc. | $342,150 |
| Genentech, Inc. | $321,379 |
| Incyte Corporation | $255,791 |
| E.r. Squibb & Sons, L.L.C. | $247,051 |
| Global Blood Therapeutics, Inc. | $244,320 |
| Takeda Pharmaceuticals U.S.A., Inc. | $234,984 |
| Amgen | $199,441 |
| Hoffmann-la Roche Limited | $180,032 |
| Novartis | $177,189 |
| Sanofi US Services Inc. | $167,955 |
| Chiesi USA, Inc. | $167,800 |
| Tandem Diabetes Care, Inc. | $148,250 |
| Sarepta Therapeutics, Inc. | $144,794 |
| Janssen Research & Development, LLC | $126,756 |
| Sobi, Inc | $112,419 |
| Albireo Pharma, Inc. | $111,269 |
| Bracco Diagnostics Inc. | $101,111 |
| Astrazeneca UK Limited | $95,895 |
| Bayer | $83,958 |
| Swedish Orphan Biovitrum AB | $83,212 |
| Kls-martin L.p. | $75,000 |
| AstraZeneca | $62,676 |
| Pacira Pharmaceuticals Incorporated | $59,701 |
| Regeneron | $52,882 |
| Bioverativ Therapeutics Inc. | $50,020 |
| Insulet Corporation | $47,239 |
| QOL Medical, LLC | $47,103 |
| Cormedix Inc. | $44,072 |
| Sanofi | $40,362 |